GlassScriptPhysician profile
Sheldon W Miller
NPI 1932280856
$12,199.03
in general payments reported to CMS, 2019-2025
46 companies · $2,826 in 2025
The $2,826 reported for 2025 was more than what 93% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $1,013 · 2021: $1,542 · 2022: $1,761 · 2023: $2,217 · 2024: $1,835 · 2025: $2,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,870 · Education: $7.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,869.87 |
| Education | $7.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $1,496.02 | 2020-2025 | Acthar |
| Neurocrine Biosciences, INC. | $1,484.96 | 2019-2025 | Ingrezza, Ongentys |
| Ucb, INC. | $1,180.63 | 2020-2025 | Briviact, Nayzilam |
| Lundbeck LLC | $708.70 | 2019-2024 | Vyepti, Rexulti |
| Amgen INC. | $700.04 | 2019-2025 | Krystexxa |
| Ani Pharmaceuticals, INC. | $577.12 | 2023-2025 | Purified Cortrophin Gel |
| Argenx US, INC. | $550.46 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Abbvie INC. | $498.35 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $443.43 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $417.67 | 2019-2021 | |
| Grifols USA, LLC | $393.71 | 2020-2025 | Gamunex-C |
| Vanda Pharmaceuticals INC. | $338.14 | 2022-2023 | Hetlioz, Fanapt |
| Paratek Pharmaceuticals, INC. | $337.22 | 2021-2025 | Nuzyra |
| Arbor Pharmaceuticals, INC. | $314.68 | 2019-2022 | |
| Sk Life Science, INC. | $278.53 | 2020-2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.